Clinical Trial Update: Telmisartan+Amlodipine Fixed Dose Combination in Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial results for a fixed-dose combination of telmisartan and amlodipine in hypertension have been completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-08-24